The Weight Reset: How GLP-1 Could Reshape Consumer Behaviour in India (Fireside Ventures)

Summary

• India is moving from early GLP-1 curiosity to active consumer adoption in 2026, shaped by everyday triggers such as weddings, holidays, postpartum periods and fitness plateaus.p.2
• As generics expand access, the first wave of value creation will come from making the GLP-1 journey work, across programs, metabolic nutrition and downstream aesthetics.p.3
• Most users drop off early when side effects rise and appetite changes intensify.p.5
• The first 4-8 weeks are critical, as users adjust to dosage and decide whether the journey feels manageable.p.6
• The real opportunity sits in the layers built around the drug: assessment, dosage support, side-effect management, metabolic nutrition, journey maintenance and aesthetics.p.8
• Baseline protein consumption in India is already structurally low, so nutrition will increasingly become part of the protocol itself.p.10
• GLP-1 could become one of the largest acquisition funnels the aesthetics economy has seen in India.p.11

Key insights

1. Access may become easier, but outcomes may become harder.p.3
2. Restaurants will rethink portions and protein, and gyms may shift from weight loss to muscle preservation.p.4
3. As drug access commoditises, retention and continuity will become the real moat in the category.p.6
4. The winners will be those helping consumers stay on the journey, sustain outcomes and manage everything that comes with it.p.7
5. Eating less is not the same as eating right, creating a new nutrition layer around the GLP-1 consumer journey.p.9
6. Aesthetic clinics are already seeing an influx of GLP-1 patients.p.11
7. The next enduring consumer health platforms in India will emerge from everything that happens after the prescription, not from treatment alone.p.12